Found 8 hits in this display Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50466562
(CHEMBL4276796)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O |r| Show InChI InChI=1S/C76H118N26O19/c1-6-40(4)61-72(119)96-48(63(110)92-49(14-10-30-88-75(81)82)64(111)94-51(24-26-58(77)106)66(113)93-50(15-11-31-89-76(83)84)65(112)101-57(73(120)121)34-43-18-22-46(105)23-19-43)12-7-8-28-86-60(108)27-25-52(67(114)100-56(36-59(78)107)70(117)97-53(32-39(2)3)71(118)102-61)95-68(115)54(33-42-16-20-45(104)21-17-42)98-69(116)55(35-44-37-85-38-90-44)99-62(109)47(91-41(5)103)13-9-29-87-74(79)80/h16-23,37-40,47-57,61,104-105H,6-15,24-36H2,1-5H3,(H2,77,106)(H2,78,107)(H,85,90)(H,86,108)(H,91,103)(H,92,110)(H,93,113)(H,94,111)(H,95,115)(H,96,119)(H,97,117)(H,98,116)(H,99,109)(H,100,114)(H,101,112)(H,102,118)(H,120,121)(H4,79,80,87)(H4,81,82,88)(H4,83,84,89)/t40-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,61-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| Article
PubMed
| 79 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 2
(Homo sapiens (Human)) | BDBM50466562
(CHEMBL4276796)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O |r| Show InChI InChI=1S/C76H118N26O19/c1-6-40(4)61-72(119)96-48(63(110)92-49(14-10-30-88-75(81)82)64(111)94-51(24-26-58(77)106)66(113)93-50(15-11-31-89-76(83)84)65(112)101-57(73(120)121)34-43-18-22-46(105)23-19-43)12-7-8-28-86-60(108)27-25-52(67(114)100-56(36-59(78)107)70(117)97-53(32-39(2)3)71(118)102-61)95-68(115)54(33-42-16-20-45(104)21-17-42)98-69(116)55(35-44-37-85-38-90-44)99-62(109)47(91-41(5)103)13-9-29-87-74(79)80/h16-23,37-40,47-57,61,104-105H,6-15,24-36H2,1-5H3,(H2,77,106)(H2,78,107)(H,85,90)(H,86,108)(H,91,103)(H,92,110)(H,93,113)(H,94,111)(H,95,115)(H,96,119)(H,97,117)(H,98,116)(H,99,109)(H,100,114)(H,101,112)(H,102,118)(H,120,121)(H4,79,80,87)(H4,81,82,88)(H4,83,84,89)/t40-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,61-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 79 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y2R expressed in CHO cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 4
(Homo sapiens (Human)) | BDBM50466562
(CHEMBL4276796)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O |r| Show InChI InChI=1S/C76H118N26O19/c1-6-40(4)61-72(119)96-48(63(110)92-49(14-10-30-88-75(81)82)64(111)94-51(24-26-58(77)106)66(113)93-50(15-11-31-89-76(83)84)65(112)101-57(73(120)121)34-43-18-22-46(105)23-19-43)12-7-8-28-86-60(108)27-25-52(67(114)100-56(36-59(78)107)70(117)97-53(32-39(2)3)71(118)102-61)95-68(115)54(33-42-16-20-45(104)21-17-42)98-69(116)55(35-44-37-85-38-90-44)99-62(109)47(91-41(5)103)13-9-29-87-74(79)80/h16-23,37-40,47-57,61,104-105H,6-15,24-36H2,1-5H3,(H2,77,106)(H2,78,107)(H,85,90)(H,86,108)(H,91,103)(H,92,110)(H,93,113)(H,94,111)(H,95,115)(H,96,119)(H,97,117)(H,98,116)(H,99,109)(H,100,114)(H,101,112)(H,102,118)(H,120,121)(H4,79,80,87)(H4,81,82,88)(H4,83,84,89)/t40-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,61-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 1.59E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PP from human Y4R expressed in CHO-K1 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 4
(Homo sapiens (Human)) | BDBM50466562
(CHEMBL4276796)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O |r| Show InChI InChI=1S/C76H118N26O19/c1-6-40(4)61-72(119)96-48(63(110)92-49(14-10-30-88-75(81)82)64(111)94-51(24-26-58(77)106)66(113)93-50(15-11-31-89-76(83)84)65(112)101-57(73(120)121)34-43-18-22-46(105)23-19-43)12-7-8-28-86-60(108)27-25-52(67(114)100-56(36-59(78)107)70(117)97-53(32-39(2)3)71(118)102-61)95-68(115)54(33-42-16-20-45(104)21-17-42)98-69(116)55(35-44-37-85-38-90-44)99-62(109)47(91-41(5)103)13-9-29-87-74(79)80/h16-23,37-40,47-57,61,104-105H,6-15,24-36H2,1-5H3,(H2,77,106)(H2,78,107)(H,85,90)(H,86,108)(H,91,103)(H,92,110)(H,93,113)(H,94,111)(H,95,115)(H,96,119)(H,97,117)(H,98,116)(H,99,109)(H,100,114)(H,101,112)(H,102,118)(H,120,121)(H4,79,80,87)(H4,81,82,88)(H4,83,84,89)/t40-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,61-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PP from human Y4R expressed in CHO-K1 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50466562
(CHEMBL4276796)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O |r| Show InChI InChI=1S/C76H118N26O19/c1-6-40(4)61-72(119)96-48(63(110)92-49(14-10-30-88-75(81)82)64(111)94-51(24-26-58(77)106)66(113)93-50(15-11-31-89-76(83)84)65(112)101-57(73(120)121)34-43-18-22-46(105)23-19-43)12-7-8-28-86-60(108)27-25-52(67(114)100-56(36-59(78)107)70(117)97-53(32-39(2)3)71(118)102-61)95-68(115)54(33-42-16-20-45(104)21-17-42)98-69(116)55(35-44-37-85-38-90-44)99-62(109)47(91-41(5)103)13-9-29-87-74(79)80/h16-23,37-40,47-57,61,104-105H,6-15,24-36H2,1-5H3,(H2,77,106)(H2,78,107)(H,85,90)(H,86,108)(H,91,103)(H,92,110)(H,93,113)(H,94,111)(H,95,115)(H,96,119)(H,97,117)(H,98,116)(H,99,109)(H,100,114)(H,101,112)(H,102,118)(H,120,121)(H4,79,80,87)(H4,81,82,88)(H4,83,84,89)/t40-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,61-/m0/s1 | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 5
(Homo sapiens (Human)) | BDBM50466562
(CHEMBL4276796)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O |r| Show InChI InChI=1S/C76H118N26O19/c1-6-40(4)61-72(119)96-48(63(110)92-49(14-10-30-88-75(81)82)64(111)94-51(24-26-58(77)106)66(113)93-50(15-11-31-89-76(83)84)65(112)101-57(73(120)121)34-43-18-22-46(105)23-19-43)12-7-8-28-86-60(108)27-25-52(67(114)100-56(36-59(78)107)70(117)97-53(32-39(2)3)71(118)102-61)95-68(115)54(33-42-16-20-45(104)21-17-42)98-69(116)55(35-44-37-85-38-90-44)99-62(109)47(91-41(5)103)13-9-29-87-74(79)80/h16-23,37-40,47-57,61,104-105H,6-15,24-36H2,1-5H3,(H2,77,106)(H2,78,107)(H,85,90)(H,86,108)(H,91,103)(H,92,110)(H,93,113)(H,94,111)(H,95,115)(H,96,119)(H,97,117)(H,98,116)(H,99,109)(H,100,114)(H,101,112)(H,102,118)(H,120,121)(H4,79,80,87)(H4,81,82,88)(H4,83,84,89)/t40-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,61-/m0/s1 | KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| 5.01E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y5R expressed in HEK293 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 1
(Homo sapiens (Human)) | BDBM50466562
(CHEMBL4276796)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O |r| Show InChI InChI=1S/C76H118N26O19/c1-6-40(4)61-72(119)96-48(63(110)92-49(14-10-30-88-75(81)82)64(111)94-51(24-26-58(77)106)66(113)93-50(15-11-31-89-76(83)84)65(112)101-57(73(120)121)34-43-18-22-46(105)23-19-43)12-7-8-28-86-60(108)27-25-52(67(114)100-56(36-59(78)107)70(117)97-53(32-39(2)3)71(118)102-61)95-68(115)54(33-42-16-20-45(104)21-17-42)98-69(116)55(35-44-37-85-38-90-44)99-62(109)47(91-41(5)103)13-9-29-87-74(79)80/h16-23,37-40,47-57,61,104-105H,6-15,24-36H2,1-5H3,(H2,77,106)(H2,78,107)(H,85,90)(H,86,108)(H,91,103)(H,92,110)(H,93,113)(H,94,111)(H,95,115)(H,96,119)(H,97,117)(H,98,116)(H,99,109)(H,100,114)(H,101,112)(H,102,118)(H,120,121)(H4,79,80,87)(H4,81,82,88)(H4,83,84,89)/t40-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,61-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| <1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y1R expressed in BHK-21 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |
Neuropeptide Y receptor type 1
(Homo sapiens (Human)) | BDBM50466562
(CHEMBL4276796)Show SMILES CC[C@H](C)[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(=O)NCCCC[C@H](NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O |r| Show InChI InChI=1S/C76H118N26O19/c1-6-40(4)61-72(119)96-48(63(110)92-49(14-10-30-88-75(81)82)64(111)94-51(24-26-58(77)106)66(113)93-50(15-11-31-89-76(83)84)65(112)101-57(73(120)121)34-43-18-22-46(105)23-19-43)12-7-8-28-86-60(108)27-25-52(67(114)100-56(36-59(78)107)70(117)97-53(32-39(2)3)71(118)102-61)95-68(115)54(33-42-16-20-45(104)21-17-42)98-69(116)55(35-44-37-85-38-90-44)99-62(109)47(91-41(5)103)13-9-29-87-74(79)80/h16-23,37-40,47-57,61,104-105H,6-15,24-36H2,1-5H3,(H2,77,106)(H2,78,107)(H,85,90)(H,86,108)(H,91,103)(H,92,110)(H,93,113)(H,94,111)(H,95,115)(H,96,119)(H,97,117)(H,98,116)(H,99,109)(H,100,114)(H,101,112)(H,102,118)(H,120,121)(H4,79,80,87)(H4,81,82,88)(H4,83,84,89)/t40-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,61-/m0/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| >1.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
Curated by ChEMBL
| Assay Description
Displacement of [125I]-PYY(1 to 36 residues) from human Y1R expressed in BHK-21 cell membranes after 2 hrs by scintillation proximity assay |
J Med Chem 61: 10519-10530 (2018)
Article DOI: 10.1021/acs.jmedchem.8b01046
BindingDB Entry DOI: 10.7270/Q2ZC85JC |
More data for this
Ligand-Target Pair | |